发明名称 Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of Bradykinin B2 receptors
摘要 Disclosed are compounds of formula (I) or the pharmaceutically acceptable non-toxic salts thereof wherein: A, B, C, and D are N or CH; X is a bond or (un)substituted CH2; R1 is lower alkenyl or (un)substituted lower alkyl; R3 is lower alkyl; and R2, R4, R5, and R6 are variables defined herein; which compounds are useful in the diagnosis and treatment of renal diseases, heart failure, hypertension, Meniere's disease, vaginal inflammation and pain, peripheral circulatory disorders, climacteric disturbance, retinochoroidal circulatory disorders, myocardial ischemia, myocardial infarction, postmyocardial infarction syndrome, angina pectoris, restenosis after percutaneous transluminal coronary angioplasty, hepatitis, liver cirrhosis, pancreatitis, ileus, diabetes, diabetic complications, male infertility or glaucoma, or for the increase of permeability of blood-brain barrier, pain, asthma, and rhinitis.
申请公布号 AU4055300(A) 申请公布日期 2000.10.23
申请号 AU20000040553 申请日期 2000.03.31
申请人 NEUROGEN CORPORATION 发明人 ROBERT W. DESIMONE;ALAN HUTCHISON;KENNETH SHAW;GEORGE D MAYNARD;JOHN M PETERSON;RICHARD LEW;HARRY L. BRIELMANN JR.
分类号 G01N33/50;A61K31/4184;A61K31/4439;A61K31/444;A61K31/496;A61K31/5377;A61P1/00;A61P1/16;A61P1/18;A61P3/04;A61P3/10;A61P9/00;A61P9/04;A61P9/08;A61P9/10;A61P9/12;A61P11/00;A61P11/02;A61P11/06;A61P13/12;A61P15/00;A61P15/02;A61P15/12;A61P25/00;A61P25/18;A61P25/22;A61P25/24;A61P27/06;C07D235/16;C07D401/06;C07D403/10;C07D471/04;G01N33/15;G01N33/566 主分类号 G01N33/50
代理机构 代理人
主权项
地址